Rachel Tyndale
From Wikipedia, the free encyclopedia
MSc, PhD, 1992, University of Toronto
CAMH
Rachel Tyndale | |
|---|---|
| Born | February 9, 1962 |
| Academic background | |
| Education | BSc, Queen's University at Kingston MSc, PhD, 1992, University of Toronto |
| Thesis | Genetically polymorphic P450IID1 (sparteine/debrisoquine - type CYP2D6): neuronal characterization and structural variants (1992) |
| Academic work | |
| Institutions | University of Toronto CAMH |
Rachel Fynvola Tyndale (born February 9, 1962) is a Canadian pharmacogeneticist. She is a Professor in the Departments of Psychiatry, and Pharmacology and Toxicology at the University of Toronto and a Canada Research Chair in Pharmacogenomics. Tyndale is also the Senior Scientist and Head of Pharmacogenetics in the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH).
Tyndale was born on February 9, 1962[1] to parents Tony and Penny Tyndale in Montreal, Quebec.[2] She completed her Bachelor of Science degree at Queen's University at Kingston before enrolling at the University of Toronto (U of T) for her Master of Science degree and PhD. Following her PhD, Tyndale accepted a postdoctoral fellowship at the University of California, Los Angeles.[3]
